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The activity of adult stem cells is regulated by signals
emanating from the surrounding tissue. Many niche
signals have been identified, but it is unclear how
they influence the choice of stem cells to remain
quiescent or divide. Here we show that when stem
cells of the adult hippocampus receive activating
signals, they first induce the expression of the tran-
scription factor Ascl1 and only subsequently exit
quiescence. Moreover, lowering Ascl1 expression
reduces the proliferation rate of hippocampal stem
cells, and inactivating Ascl1 blocks quiescence exit
completely, rendering them unresponsive to acti-
vating stimuli. Ascl1 promotes the proliferation of
hippocampal stem cells by directly regulating the
expression of cell-cycle regulatory genes. Ascl1 is
similarly required for stem cell activation in the adult
subventricular zone. Our results support a model
whereby Ascl1 integrates inputs from both stimula-
tory and inhibitory signals and converts them into a
transcriptional program activating adult neural stem
cells.
INTRODUCTION
Adult stem cells maintain tissue function and integrity throughout
the lifetime of an organism. They produce mature progenies to
replace short-lived cells and repair tissue damage while main-
taining their numbers through self-renewing divisions (Simons
and Clevers, 2011). Many tissue stem cells are relatively quies-
cent, which delays their attrition andminimizes the accumulation
of deleterious mutations (Orford and Scadden, 2008). The transit
of stem cells between quiescent and activated states is not well
understood in most systems. Elucidating the mechanisms that
control the activation of tissue stem cells is an important goal
in stem cell biology.
A variety of extracellular signals present in stem cell niches
have been shown to influence the activity of tissue stem cells
(Fuchs et al., 2004; Goldstein and Horsley, 2012; Kuang et al.,Ne2008). For example, BMP signaling induces quiescence, while
Wnts promote proliferation of skin and blood stem cells (Blank
et al., 2008; Fuchs et al., 2004). However, the cell-intrinsic mech-
anisms that mediate the activity of extrinsic signals and promote
stem cell quiescence or proliferation are poorly characterized.
Niche signals might act by inducing the expression or activity
of transcription factors that in turn regulate the large number of
genes differentially expressed between quiescent and active
stem cells (Lien et al., 2011; Martynoga et al., 2013; Venezia
et al., 2004). Transcription factors have indeed been shown to
regulate stem cell activity in various tissues by controlling their
proliferation, survival, or differentiation (Akala and Clarke,
2006; Goldstein and Horsley, 2012). However, it is not known
in most instances how these factors are regulated (Niu et al.,
2011; Osorio et al., 2008).
In the adult mammalian nervous system, neural stem cells
(NSCs) are found mostly in two regions of the anterior brain,
the dentate gyrus (DG) of the hippocampus and the ventricu-
lar-subventricular zone (V-SVZ) lining the lateral ventricles,
where stem cells produce new neurons that integrate into
neuronal circuits of the hippocampus and olfactory bulb, respec-
tively (Fuentealba et al., 2012; Ming and Song, 2011). Most adult
NSCs are quiescent and rest in G0, with only a small fraction pro-
gressing through the cell cycle at any time. NSC divisions result
in the generation of transit-amplifying cells or intermediate pro-
genitor cells (IPCs) that undergo a limited number of rapid divi-
sions before they exit the cell cycle and differentiate into neurons
(Ming and Song, 2011; Ponti et al., 2013). Clonal analysis in the
adult mouse hippocampus in vivo has provided evidence that
hippocampal NSCs, also called radial glia-like cells (RGLs), are
multipotent and can generate both neurons and astrocytes,
and that they use two modes of divisions to self-renew. Some
RGLs divide asymmetrically to generate a new RGL and an
IPC or an astrocyte, while others divide symmetrically into two
new RGLs (Bonaguidi et al., 2011).
A particularly important feature of hippocampal neurogenesis
is its regulation by a variety of physiological stimuli (Ming and
Song, 2011). Neurogenesis in the hippocampus declines sharply
with age, due in part to a reduction of the fraction of RGLs that
divide, and it is suppressed by stress and depression (Lee
et al., 2011;Ming andSong, 2011). Conversely, an enriched envi-
ronment, task learning, or seizures stimulate hippocampal neu-
rogenesis, in part by stimulating RGL divisions (Kronenberguron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1085
Figure 1. Expression of Ascl1 by Proliferating Stem and Progenitor Cells in the Adult Hippocampus
(A) Colocalization of Ascl1 protein (green) and proliferation marker Ki67 (red) shows that Ascl1 is expressed in proliferating cells in the dentate gyrus (DG) of a P60
mouse. Counterstained by DAPI (white).
(B) Ascl1 (green), MCM2 (a marker of cell cycle and G0 to early G1 transition, red), and neural stem cell marker GFAP (white) are colocalized in an activated radial
glia-like stem cell (RGL). The z stack of the merged confocal picture is shown along the x axis (top) and the y axis (right).
(C) The percentage of activated (MCM2+) and Ascl1-expressing (Ascl1+) RGLs in the DG of P60 mice show that Ascl1 is expressed in a third of activated RGLs.
n = 3.
(D) Labeling for Ascl1 (green), the intermediate progenitor cell (IPC) marker Tbr2 (red), and GFAP (white) in a P60 DG show that Ascl1 is expressed in both
Tbr2+ (yellow arrowhead) and Tbr2 (white arrow) GFAP IPCs. Scale bars, 20 mm in (A) and (D) and 10 mm in (B). Values represent mean values, and error bars
represent SDs.
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Ascl1 Activates Adult Hippocampal Stem Cellset al., 2003; Ming and Song, 2011). Some of the extracellular sig-
nals that regulate RGL activity have been identified (Ming and
Song, 2011). In particular, the BMP and Notch signaling path-
ways maintain RGLs in a quiescent state (Ables et al., 2010;
Ehm et al., 2010; Mira et al., 2010), while theWnt and IGF-1 path-
ways, among others, promote RGL divisions and stimulate neu-
rogenesis (Bracko et al., 2012; Jang et al., 2013; Lie et al., 2005;
Qu et al., 2010). Little is known, however, of how the activity of
physiological stimuli or extrinsic signals is transduced inside
RGLs to control their divisions. The orphan nuclear receptor
Tlx is required to maintain RGLs in proliferation (Niu et al.,
2011; Qu et al., 2010; Zhang et al., 2008), but how Tlx expression
and activity are regulated has not been addressed.
The proneural transcription factor achaete-scute homolog 1
(Ascl1/Mash1) is an important regulator of neurogenesis in the
embryonic nervous system. It is expressed by dividing progeni-
tors and promotes their proliferation, specification, and differen-
tiation into neurons (Bertrand et al., 2002; Castro et al., 2011).
Moreover, ectopic expression of Ascl1 can reprogram various
cell types into neurons (Berninger et al., 2007; Yang et al.,
2011). Ascl1 is also expressed in the DG and V-SVZ of the adult
rodent brain, but its function there has not been examined. Ascl1
adult expression is mostly confined to IPCs (Lugert et al., 2012;
Parras et al., 2004; Pastrana et al., 2009), but recent genetic line-
age-tracing experiments have established that it is also present
in self-renewing stem cells in both the V-SVZ and hippocampus
(Kim et al., 2011). Consistent with this finding, Ascl1 was found
expressed by a small subset of cycling stem cells in both neuro-
genic zones (Breunig et al., 2007; Kim et al., 2011). Here we show1086 Neuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc.that Ascl1 expression is rapidly induced by neurogenic signals in
hippocampal RGLs, and that Ascl1 has a crucial role in RGL acti-
vation in both DG and V-SVZ. Ascl1 is specifically expressed in
activated adult stem cells and is specifically required for the
exit of stem cells from quiescence.
RESULTS
Ascl1 Is Expressed by Activated Stem Cells in the Adult
Hippocampus
To study the function of Ascl1 in hippocampal neurogenesis, we
first characterized its expression in the adult hippocampus. La-
beling of 2-month-old mouse brains with a monoclonal antibody
against Ascl1 showed that in the hippocampus, Ascl1-express-
ing cells are restricted to the subgranular zone (SGZ) of the DG
(Figure 1A). Double labeling for Ascl1 and the cell proliferation
marker Ki67 showed that most Ascl1-expressing cells are prolif-
erating (Figure 1A). Double labeling for Ascl1 andmarkers of pro-
genitor cells of the DG neurogenic lineage showed that Ascl1 is
expressed by three distinct progenitor cell populations. It is ex-
pressed by a small subset of RGLs, identified by their radial
morphology and expression of GFAP. Most Ascl1-positive
RGLs are activated, as 83.3% ± 16.7% of them express the
cell cycle and cell activation marker MCM2 (Machida et al.,
2005; Niu et al., 2011) (Figures 1B and 1C). Ascl1-positive
RGLs represent 35.6% ± 3.2% of activated (MCM2+) RGLs
and 2.0%± 0.7%of all RGLs (Figure 1C). Ascl1 is also expressed
by nonradial GFAP+ cells in the SGZ, which are also considered
to be hippocampal NSCs (Lugert et al., 2010; Suh et al., 2007),
Figure 2. Induction of Ascl1 Expression in
Hippocampal Stem Cells by Neurogenic
Stimuli
(A and B) Administration of kainic acid (KA) in 8- to
9-week-old mice and analysis of Ascl1, MCM2,
and GFAP expression 24 hr later. The area boxed
in (A), top (Saline), and enlarged on the right, and
the white arrow in the bottom panel (KA) show
an RGL that expresses Ascl1 and is activated
(MCM2+). The area boxed in (A), bottom (KA), and
the yellow arrowheads show Ascl1+ RGLs that are
still quiescent (MCM2). The percentages of RGLs
expressing Ascl1 and MCM2 24 hr after injection
(B) show an increased number of quiescent RGLs
expressing Ascl1 in KA-injected mice, while the
number of activated RGLs is not changed. p
values, Ascl1+MCM2 RGLs in saline versus KA =
0.0074; MCM2+ RGLs in saline versus KA =
0.6492. n = 4 (saline) and 5 (KA).
(C and D) Inactivation of the RBPJk gene by in-
jection of tamoxifen (TAM) in conditional RBPJk-
mutant mice on 5 consecutive days starting at P90
and analysis of Ascl1, MCM2, and GFAP expres-
sion at P102 show that there are more Ascl1+ and
activated RGLs in the DG of an RBPJk cKOmouse
(arrow and boxed area in lower panel shown
enlarged on the right) than in a control mouse (WT,
enlarged area in upper panel) (C). The percentages
of RGLs that express MCM2 and Ascl1 in the DG
of WT and RBPJk cKO mice (D) show an increase
in the number of quiescent Ascl1+ RGLs in RBPJk
cKO mice (black bar), suggesting that blocking
Notch signaling induces Ascl1 expression before
RGLs exit quiescence. p values, Ascl1+ RGLs in
WT versusRBPJk cKO < 0.0001;MCM2+RGLs inWT versusRBPJk cKO < 0.0001; Ascl1+MCM2RGLs inWT versusRBPJk cKO = 0.0911. n = 5 forWT, n = 7 for
RBPJk cKO. Scale bars, 20 mm in main panels and 10 mm in enlarged panels. Values represent mean values, and error bars represent SDs.
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Ascl1 Activates Adult Hippocampal Stem Cellsand by IPCs, characterized by their SGZ location, proliferative
state, and lack of GFAP expression (Figure 1D). Ascl1-positive
IPCs represent 13.5% ± 4.1% of all IPCs and are subdivided
into two subsets that differ in the expression of the IPC marker
Tbr2 (Kempermann et al., 2004; Ming and Song, 2011). Ascl1
is not expressed by more mature cells in the lineage, including
doublecortin (DCX)+ neuroblasts and NeuN+ granule neurons
(Figure S1; data not shown). Together, these data agreewith pre-
vious reports showing that Ascl1 expression is restricted to the
earliest stages of the neurogenic lineage of the adult DG,
including proliferating RGLs (Breunig et al., 2007; Kim et al.,
2011) and early IPCs (Lugert et al., 2010, 2012), and that it is
downregulated before IPCs begin to express neuronal markers
and exit the cell cycle.
Ascl1 Expression in Hippocampal Stem Cells Is Induced
by Neurogenic Stimuli
The fact that Ascl1 expression is restricted to activated RGLs
suggested that this factor might be induced by signals that pro-
mote RGL activity and neurogenesis in the hippocampus. To
address this possibility, we examined Ascl1 expression in mice
treated with the ionotropic glutamate receptor agonist kainic
acid (KA), a neurogenic molecule that induces progenitor divi-
sions in the DG (Lugert et al., 2010). A single injection of KA in
8- to 9-week-old wild-type (WT) mice produced, as expected,Nea robust increase in the number of MCM2+ RGLs in the DG,
which became detectable 2 days after injection (Figure S2).
Remarkably, KA induced Ascl1 expression in RGLs with more
rapid kinetics, as the number of Ascl1+ RGLs was already
increased 24 hr after injection of KA (Figure S2). Thus, a signifi-
cant fraction of quiescent (MCM2) RGLs expressed Ascl1 at
24 hr after injection (7.8%± 1.3%Ascl1+MCM2RGLs in KA-in-
jected mice and 1.4% ± 0.9% in saline-injected mice at 24 hr;
Figures 2A, 2B, and S2). The number of Ascl1+ quiescent
RGLs decreased, while the number of activated RGLs increased
at 2 days and 4 days (Figure S2). Together, these data indicate
that KA administration induces Ascl1 expression in RGLs that
are still quiescent. Therefore, Ascl1 induction precedes RGL
activation.
To determine whether antineurogenic stimuli also regulate
Ascl1 expression in the DG, we examined Notch signaling. Dele-
tion of the Notch pathway component RBPJk has been shown to
transiently induce the proliferation of hippocampal RGLs, fol-
lowed later by a depletion of RGLs (Ehm et al., 2010). We deleted
RBPJk from RGLs by injecting tamoxifen in 3-month-old mice
carrying an inducible RBPJk-mutant allele (Glast::CreERT2;
RBPJkloxP/loxP; Rosa26R-stop-YFP mice, called thereafter
RBPJk cKOmice). Examination of the hippocampus 7 days later
revealed a dramatic increase in the numbers ofMCM2+ activated
RGLs and of Ascl1-expressing RGLs in RBPJk cKO miceuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1087
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Ascl1 Activates Adult Hippocampal Stem Cellscompared with control mice, demonstrating that loss of Notch
signaling stimulates both the proliferation of RGLs and the
expression of Ascl1 (Figures 2C and 2D). A fraction of RGLs in
RBPJk cKO DGs expressed Ascl1, and not MCM2 (3.60% ±
1.50% inRBPJk cKO versus 0.25%± 0.25% in control mice; Fig-
ure 2D), suggesting that like KA administration, inactivation of
the Notch pathway in RGLs sequentially promotes Ascl1 expres-
sion and quiescence exit. We also examined the effect of volun-
tary exercise on RGL proliferation and expression of Ascl1 and
found that it did not significantly increase proliferation of hippo-
campal RGLs, but only that of IPCs, as previously reported
(Klempin et al., 2013). Together, our results demonstrate that
neurogenic stimuli rapidly induce Ascl1 expression in quiescent
RGLs, which in turn suggests that this factor might be implicated
in RGL activation.
Ascl1 Is Absolutely Required for the Exit of RGLs
from Quiescence
To directly address the role ofAscl1 in the activation of DGRGLs,
we generated triple-transgenic mice that were homozygous for a
conditional mutant allele of Ascl1 (Pacary et al., 2011) and also
carried the Glast-CreERT2 allele to delete Ascl1 in RGLs in a
tamoxifen-dependent manner (Mori et al., 2006) and the
Rosa26-floxed stop-YFP reporter transgene to identify cells hav-
ing undergone Cre-mediated recombination by their expression
of YFP (Srinivas et al., 2001). Administration of tamoxifen for
5 days to postnatal day 60 (P60) triple-transgenic mice and con-
trol mice (carrying Glast-CreERT2 and Rosa26-floxed stop-YFP,
but WT for Ascl1) resulted in widespread induction of YFP in
radial GFAP+, Nestin+ RGLs (Figures 3A, 3B, and data not
shown). However, examination by immunolabeling revealed
that a fraction of SGZ cells that expressed YFP and had therefore
recombined the Rosa26-floxed stop-YFP locus also expressed
Ascl1 and had therefore not recombined the Ascl1flox locus, indi-
cating that recombination at the two loci was partially uncoupled
(Vooijs et al., 2001). We also examined triple-transgenic mice
carrying a different conditional mutant allele of Ascl1, in which
a PGK promoter-neo cassette remained inserted on the 30 side
of the Ascl1 locus (Ascl1neoflox mice; Figures 3C and S3A). Inter-
estingly, even without tamoxifen-induced recombination, Ascl1
RNA and protein expressions were significantly reduced in the
DG of these mice compared with WT mice (Figures 3D and
S3B), suggesting that Ascl1neoflox is a hypomorphic allele (Nagy
et al., 1998). Analysis of Ascl1neoflox mice at P10 did not reveal
any overt morphological defect of the DG, and the rate of RGL
proliferation was similar to that found in WT mice, indicating
that the hypomorphic allele of Ascl1 does not result in a develop-
mental defect in the DG (Figure S3). Tamoxifen administration to
these mice at P60–P64 resulted in undetectable Ascl1 expres-
sion in the DG at P90 (Ascl1neocKO mice; Figures 3C, 3D, S3A,
and S3B). We therefore used Ascl1neocKO mice in the rest of
this study to examine the effect of loss of Ascl1 on hippocampal
neurogenesis, and we used Ascl1neoflox mice to examine the ef-
fect of a reduced expression of Ascl1.
To determine whether Ascl1 deletion has an impact on DG
RGLs, we administered tamoxifen at P60–P64 and examined
Ascl1neocKO mice 1 month later, at P90. Double labeling for
YFP and for MCM2, Ki67, or bromodeoxyuridine (BrdU) after a1088 Neuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc.2 hr pulse revealed a near-complete absence of proliferating
YFP+ cells in the SGZ of Ascl1neocKO mice (Ascl1neocKO mice
versus WT mice, 19.65 ± 19.65 versus 4,635 ± 921 YFP+
MCM2+ cells; 0 versus 2,875 ± 815 YFP+ KI67+ cells; 9.8 ± 4.9
versus 471.6 ± 115.5 YFP+ BrdU+ cells), while proliferating cells
were present in Ascl1neoflox mice, albeit in reduced numbers
(2,233 ± 632 MCM2+ cells; 1,225 ± 298 KI67+ cells; 142.8 ±
10.2 BrdU+ cells; Figures 3E–3H). Moreover, triple labeling for
YFP, GFAP, and MCM2 to mark activated stem cells or Ki67 to
mark proliferating stem cells demonstrated a complete absence
of recombined RGLs that were activated or proliferating in
Ascl1neocKO mice, while activated and cycling RGLs were pre-
sent, but less numerous, in Ascl1neoflox mice than in WT mice
(Ascl1neocKO versus Ascl1neoflox versus WT mice, 0 versus
126.3 ± 26.3 versus 281.2 ± 70.1 MCM2+ cells; 0 versus 66.0 ±
29.5 versus 161.2 ± 48.5 KI67+ cells; Figures 3I–3K; see also Fig-
ures S3D–S3G for measures of proliferation in the DG of Ascl1flox
and Ascl1cKO mice). Rarely dividing RGLs, characterized by
their capacity to retain BrdU, were labeled in tamoxifen-injected
P90 mice by 10 days of BrdU administration followed by 20 days
of chase (Figure 3L). BrdU label-retaining cells were present
in WT mice and to a lesser extent in Ascl1neoflox mice, but
were again completely absent in Ascl1neocKO mice (0 cells in
Ascl1neocKO mice; 9.7 ± 4.9 cells in Ascl1neoflox mice; 43.8 ±
6.2 cells in WT mice; Figure 3L). We could thus demonstrate by
several independent methods the complete inability of RGLs to
exit quiescence and divide in the absence ofAscl1, and therefore
establish that Ascl1 is essential for activation of RGLs in the adult
hippocampus. Interestingly, Ascl1 deletion had no significant ef-
fect on the rate of RGL proliferation in the postnatal DG. When
Ascl1 was deleted by tamoxifen administration in Ascl1neocKO
mice at P7, RGLs continued to proliferate at P10 at a rate that
was not significantly different from that seen in WT mice (Fig-
ure S3H). Therefore, the absolute requirement of Ascl1 for RGL
activity is specific to the adult DG.
Dividing RGLs in the adult hippocampus generate IPCs that
proliferate before producing postmitotic granule neurons (Bona-
guidi et al., 2011; Kempermann et al., 2004). Since RGLs require
Ascl1 to divide, the production of IPCs and their neuronal prog-
eny might also depend on Ascl1 function. The absence of Ki67+,
MCM2+, and BrdU+ cells in the SGZ of Ascl1neocKO mice (Fig-
ures 3F–3H) already suggested that IPCs are indeed missing in
these mice. We further examined neurogenesis by double label-
ing the hippocampus of Ascl1neocKO mice for YFP and for Tbr2
tomark IPCs, for DCX tomark neuroblasts, and for NeuN tomark
granule neurons (Kempermann et al., 2004; Ming and Song,
2011). No YFP+ cells expressed these markers in the DG of
Ascl1neocKO mice at P90, demonstrating that no new IPCs or
granule neurons were produced in these mice (Figures S3I–
S3K; data not shown). Ascl1 is therefore absolutely required for
the generation of IPCs and for neurogenesis in the hippocampus.
Ascl1 Is Required for RGL Activation in the V-SVZ
We also examined neurogenesis in the V-SVZ of Ascl1neocKO
mice to determine whether the role of Ascl1 in adult RGLs ex-
tends to the other main neurogenic region of the adult rodent
brain. Analyzing the expression of GFAP, DCX, EGFR, and
GFP in Ascl1neocKO and WT mice showed that deletion of
Figure 3. Block of Activation and Proliferation of Hippocampal Stem Cells by Conditional Inactivation of Ascl1
(A and B) Administration of tamoxifen at P60–P64 inGlast-CreERT2; Rosa26-floxed stop-YFPmice followed by the analysis of YFP expression at P64 (A) and the
percentage of RGLs that express YFP (B) show the high efficiency of recombination of the YFP reporter allele. n = 3.
(C) Presentation of the five mouse lines analyzed in this study, including (first column) their names, (second column) the Ascl1 allele they carry (WT, flox, or
neoflox), (third column) the Rosa26-floxed stop-YFP reporter transgene they all carry (R26 YFP), (fourth column) whether they carry (+) or do not carry () the
deleter alleleGlast-CreERT2 (CreER), and (fifth column) whether the tamoxifen injection they have all received (TAM, +) results in inactivation of Ascl1 and the YFP
reporter (Rec, Yes) or not (Rec, No).
(D) Conditional inactivation of the Ascl1 gene by tamoxifen administration at P60–P64 and analysis at P90 of Ascl1 transcripts by quantitative RT-PCR on laser-
capture-microdissected SGZ tissue shows that Ascl1 expression is strongly reduced in Ascl1neoflox mice compared to WTmice and is eliminated in Ascl1neocKO
mice. The graph shows expression levels normalized to Gapdh and relative to Ascl1 expression in WT. n = 3 in each genotype.
(E–H) Labeling for the proliferation marker Ki67 and for YFP to mark recombined cells (right panels are enlargements of the areas boxed in left panels) (E) and the
total numbers per DG of MCM2+ cells (F), Ki67+ cells (G), and BrdU+ cells 2 hr after BrdU administration (H) show that cells do not proliferate in the DG of P90
Ascl1neocKOmice, and that the lower level of Ascl1 expression in Ascl1neoflox mice results in reduced proliferation compared to WT mice. p values in WT versus
Ascl1neocKO, MCM2+ cells = 0.058; Ki67+ cells = 0.031; BrdU+ cells = 0.0162. n = 5 for WT, n = 4 for Ascl1neocKO (F), 4 (G), and 3 (H).
(I–L) Labeling for Ki67 and GFAP (I) and total numbers per DG of MCM2+ and Ki67+ RGLs (J and K) and BrdU+ cells following prolonged administration and chase
of BrdU (L) demonstrate the absence of activated, proliferating, and BrdU label-retaining RGLs in Ascl1neocKO mice and their reduced numbers in Ascl1neoflox
mice. p values inWT versus Ascl1neocKO, MCM2+ cells = 0.016; Ki67+ cells = 0.038; BrdU+ cells = 0.0084. n = 5 forWT, n = 4 for Ascl1neocKO (J), 4 (K), 5 (L, WT), 3
(L, Ascl1neoflox), and 3 (L, Ascl1neocKO). Scale bars, 40 mm in (A) and (E) and 10 mm in (I). Values represent mean values, and error bars represent SDs.
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Ascl1 Activates Adult Hippocampal Stem CellsAscl1 results in a severe decrease in the fraction of RGLs of the
V-SVZ that are activated (GFAP+ EGFR+) and proliferate (BrdU
label retaining), and in a severe reduction in the production ofNeDCX+ neuroblasts (Figures 4 and S4). Therefore, Ascl1 is essen-
tial for NSC activation and proliferation and for neurogenesis in
the two main neurogenic regions of the adult brain.uron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1089
Figure 4. Block of Activation and Proliferation of V-SVZ Stem Cells
by Conditional Inactivation of Ascl1
(A–D) Labeling for the activation marker MCM2 (right panels are enlargements
of the areas boxed in left panels; arrowheads point to MCM2+ cells) (A) and
numbers of MCM2+ cells (B), activated RGLs identified by coexpression of
GFAP and EGFR (C) among recombined YFP+ cells in the dorsal (dlSVZ),
medial, lateral (l/mSVZ), and ventral (vSVZ) V-SVZ, and BrdU label-retaining
cells in the whole SVZ following prolonged administration and chase of BrdU
(D) show that RGLs are not activated and do not proliferate in the V-SVZ of
P112 Ascl1neocKO mice. p values in WT versus Ascl1neocKO, MCM2+ cells =
0.00014 in dlSVZ, < 0.0001 in l/mSVZ, < 0.0001 in vSVZ; n = 5; GFAP+, EGFR+
cells = 0.00033; n = 4; BrdU label-retaining cells = 0.0056; n = 4. Scale bars,
200 mm in whole panels and 50 mm in enlarged panels. Values represent mean
values, and error bars represent SDs.
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Ascl1 Activates Adult Hippocampal Stem CellsAscl1 Acts Cell Autonomously to Promote RGL
Proliferation
Ascl1 is expressed in proliferating RGLs, and the loss ofAscl1 re-
sults in an arrest of RGL proliferation, suggesting that this gene is
required in RGLs to promote their divisions. However, Ascl1 is
also expressed in some IPCs, raising the alternative possibility
that Ascl1 is primarily required for the generation and/or division
of IPCs, and that the arrest of RGL divisions is a secondary
consequence of the loss of IPCs. In particular, a loss of IPCs
might disrupt Notch signaling in the SGZ, resulting in a transient
increase in RGL proliferation, followed later by a reduction of
proliferation due to RGL exhaustion (Ables et al., 2010; Ehm1090 Neuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc.et al., 2010; Lavado et al., 2010). To address this possibility,
RGL proliferation was monitored in Ascl1neocKO mice just
4 days after the beginning of tamoxifen administration at P60.
RGLs had already stopped dividing in P64 Ascl1neocKO mice,
indicating that the effect of Ascl1 deletion on RGL proliferation
is rapid and therefore likely direct (Figures 5A and 5B). Moreover,
although RGLs in the DG of P64 Ascl1neocKO mice are mostly
YFP+ and have therefore recombined (Figures 3B and 5A), WT
Tbr2+ IPCs and DCX+ neuroblasts that were produced by
RGLs before tamoxifen administration at P60–P64 are still pre-
sent (Figure 5C). This suggests that the RGL proliferation defect
is not the consequence of a loss of Ascl1-mutant IPCs and
neuroblasts, i.e., Ascl1 is required cell autonomously for RGL
divisions.
To more rigorously address the cell autonomy or noncell au-
tonomy of Ascl1 function, we performed a mosaic analysis. We
activated CreERT2 in a fraction of RGLs with only one injection
of tamoxifen at P60, resulting 1 month later in an intermingling
of recombined YFP-positive RGLs and nonrecombined YFP-
negative RGLs and their progenies (Figure 5D). In WT mice that
had received a single tamoxifen injection, a fraction of recom-
bined YFP+ RGLs was proliferating (Figures 5E and 5F). In
contrast, recombined YFP+ RGLs did not proliferate in mosaic
Ascl1neocKO and Ascl1cKOmice, irrespective of the recombina-
tion efficiency (Figures 5E, 5F, and S5). Therefore, the prolifera-
tion defect of Ascl1-mutant RGLs cannot be rescued by the
presence of nearby WT cells, demonstrating that Ascl1 is
required cell autonomously in RGLs for their divisions.
Ascl1-Deficient RGLs Do Not Respond to
Mitogenic Stimuli
Next, we examined the phenotype of the cells remaining in the
SGZ after Ascl1 deletion. Antibody labeling of the DG of P90
Ascl1neocKO mice revealed that these cells retain the typical
radial morphology of RGLs and maintain expression of the
RGL markers GFAP, Nestin, and Sox2 and do not express the
astrocytic marker S100b or the oligodendrocyte progenitor
marker Olig2 (Figures 6A, 6B, and S6A–S6C). RT-PCR analysis
showed that expression of p16INK4a/Cdkn2a was not elevated
in the DG of Ascl1neocKO mice, suggesting that RGLs in these
mice do not become senescent (Molofsky et al., 2006). More-
over, RGLs in Ascl1neocKO maintained normal levels of the cy-
clin-dependent kinase inhibitor p57Kip2, which is required for
quiescence of hippocampal RGLs (Furutachi et al., 2013). These
data, together with the lack of MCM2 expression in Ascl1-defi-
cient RGLs (Figure 3J), show that Ascl1 is not required for the
maintenance of RGLs, but specifically for their activation, and
that loss of Ascl1 keeps RGLs in an inactive and undifferentiated
state.
Although Ascl1-deficient RGLs are unable to proliferate when
in a steady state, they might still be able to respond to a potent
neurogenic stimulus such as KA. We therefore injected tamox-
ifen in Ascl1neocKO mice at P60 to delete Ascl1, then injected
KA at P86 and analyzed the DG at P90. KA failed to activate
RGLs in Ascl1neocKO mice, while it strongly activated them
in WT mice (Figures 6E and 6F). Therefore, loss of Ascl1 in
RGLs results in an inactive state that cannot be reversed by
KA stimulation. We also confirmed the inactivated state of
Figure 5. Cell-Autonomous Function of
Ascl1 in Hippocampal Stem Cell Prolifera-
tion
(A–C) RGLs have ceased to proliferate in the
Ascl1neocKO DG as early as 4 days after the first
tamoxifen injection (A and B). Percentages of
RGLs expressing Ki67 in each genotype (B).
Nonrecombined (YFP) Tbr2+ IPCs and DCX+
neuroblasts remain in the DG of the Ascl1neocKO
mouse at P64 (C), but they cannot rescue
the proliferation defect of recombined (YFP+)
RGLs (B). p value, Ki67+ RGLs in WT versus
Ascl1neocKO = 0.0019. n = 3 in each genotype.
(D–F) A single injection of tamoxifen results in
recombination in only a fraction of RGLs, and
nonrecombined RGLs produce YFP DCX+ neu-
roblasts in both WT and Ascl1neocKO mice (D). In
the Ascl1neocKO DG, nonrecombined (YFP, ar-
row) RGLs proliferate, but recombined (YFP+)
RGLs do not, demonstrating that the presence of
WT RGLs and their progeny does not rescue the
proliferation defect of Ascl1-deficient RGLs (E and
F). Total numbers of Ki67+ RGLs among YFP+
and YFP RGLs in the two genotypes (F). p value,
Ki67+ YFP+ RGLs in WT versus Ascl1neocKO =
0.0003. n = 3 (WT) and 6 (Ascl1neocKO). Scale
bars, 20 mm in (A), (C), and (E) and 40 mm in (D).
Values represent mean values, and error bars
represent SDs.
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assay in the presence of mitogens (Ehm et al., 2010). The DG
was dissected from 7- to 8-week-old mice and dissociated,
and single-cell suspensions were cultured at clonal density
in the presence of FGF2 and EGF. Cultures of WT DG cells
produced large numbers of primary neurospheres that gener-
ated secondary neurospheres when passaged. In contrast,
Ascl1neocKO DG cell cultures produced very few neurospheres,
and antibody labeling showed that these neurospheres main-
tained expression of Ascl1 and therefore originated from cells
that had escaped recombination (Figures 6G, 6H, and S6E).
Therefore, Ascl1-deficient RGLs are quiescent and unable to
respond to mitogens and divide in vitro.
We next examined whether the inactive state of Ascl1-
deficient RGLs was stable over a longer period. Analysis of
Ascl1neocKOmice 5months afterAscl1deletion, at P210, showed
that RGLs retained a radial morphology and GFAP expression
and remained Ki67 negative (Figure 6I). Interestingly, while the to-
tal number of RGLs in the DGofWTmice decreased considerably
between P65 and P90 and decreased further at P210 (22,116 ±
1,681 at P65, 14,453 ± 1,021 at P90, and 12,516 ± 1,063 at
P210), their number inAscl1neocKOmice did not change between
P65 and P90 and decreased only slightly and nonsignificantly at
P210 (24,533 ± 1,399 at P65, 26,098 ± 1,913 at P90, and
20,764 ± 395 at P210; Figure 6J). As the age-related attrition of
hippocampal RGLs is thought to result from non-self-renewing
divisions (Bonaguidi et al., 2012; Encinas et al., 2011), the mainte-
nance of RGL numbers in older Ascl1neocKO mice supports the
finding that RGLs do not divide in these mice.NeAscl1 Directly Regulates Cell-Cycle Genes in
Hippocampal Stem Cells
To identify target genes that mediate the proliferative role of
Ascl1 in hippocampal stem cells, we examined the genome-
wide binding of Ascl1 in adult hippocampus-derived NSCs
(Knobloch et al., 2013) by chromatin immunoprecipitation-
sequencing (ChIP-seq) with an anti-serum against Ascl1 (Figures
7 and S7). Ascl1 was bound to 7,826 high-confidence sites in the
genome of AH-NSCs (Figure 7A), a majority of which mapped to
enhancers previously identified in cultured NSCs (Figure 7B;
Martynoga et al., 2013). Moreover, a large fraction of enhancers
active in proliferating NSCs featured an Ascl1-binding event in
AH-NSCs (Figure 7C).
We then established a list of the genes associated with an
Ascl1-binding event in the AH-NSC genome (Table S1) and
searched for candidate direct targets of Ascl1, i.e., genes
that are both bound by Ascl1 and misregulated in RGLs of
Ascl1neocKO. We reasoned that since Ascl1 is required for
NSC proliferation in both DG and V-SVZ, it might regulate
some of the same genes in the two tissues. We therefore inter-
sected our list of Ascl1-bound genes with a recently published
list of V-SVZ genes enriched in activated NSCs compared with
quiescent NSCs (Figure S7; Table S2) (Codega et al., 2014).
The 250 genes that are both bound by Ascl1 in AH-NSCs and en-
riched in activated V-SVZ NSCs include, in addition to known
Ascl1 targets such as the Notch ligands Dll1 and Dll3 (Castro
et al., 2011), several cell-cycle regulators such as E2f1, Ccnd2,
Cdc6, and Skp2. To establish whether these genes are regulated
by Ascl1 in DG RGLs, we used fluorescence-activated celluron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1091
Figure 6. Unresponsiveness of Ascl1-Deficient Hippocampal Stem Cells to Extrinsic Stimuli
(A and B) Ascl1-deficient RGLs in P90 Ascl1neocKO mice retain a neural stem cell phenotype characterized by expression of the neural stem/progenitor cell
markers Nestin, Sox2, and GFAP and a radial morphology. We note that Nestin remains expressed in Ascl1-mutant quiescent hippocampal RGLs, albeit at a
lower level than in WT RGLs (not shown), whereas it is not expressed in quiescent RGLs in the V-SVZ (Codega et al., 2014). n = 3 in each genotype.
(C) Quantitative RT-PCR analysis of the cyclin-dependent kinase inhibitor p16INK4a/Cdkn2a in the laser-capture-microdissected SGZ shows that expression of
this marker of RGL senescence is barely detectable and not increased in the Ascl1neocKO SGZ compared with WTmice. Expression levels normalized toGapdh.
n = 3 in each genotype.
(D) Expression of the cyclin-dependent kinase inhibitor p57Kip2, a marker of quiescent RGLs, is similar in the DG of WT and Ascl1neocKO mice.
(E and F) KA administration stimulates cell proliferation in the SGZ of WTmice, but not in the SGZ of Ascl1neocKOmice. Total numbers of MCM2+ cells in the SGZ
in each condition (F). p value, MCM2+ cells in WT versus Ascl1neocKO = 0.0183. n = 3 in each condition.
(G and H) Clonal cultures of dissociated DG cells produced a large number of primary neurospheres from WT DG and only few neurospheres from Ascl1neocKO
DG. Total numbers of spheres obtained from clonal cultures of one dissociated DG. p value = 0.0060. n = 3 in each genotype. Further analysis showed that the few
neurospheres from Ascl1neocKO DG have escaped recombination and express Ascl1 (see Figure S6E).
(I) At 5 months after Ascl1 inactivation, SGZ cells in Ascl1neocKO mice retain morphological and molecular features of RGLs and remain nonproliferative. The
boxed areas are enlarged on the right and show a proliferating RGL in WT and a nonproliferating RGL in Ascl1neocKO. Note the accumulation of YFP+ granule
neurons above the SGZ in WT, and not in Ascl1neocKO, mice.
(J) RGL numbers decrease significantly with age in WT mice, while RGL numbers are not significantly different in Ascl1neocKOmice at P65, P90, and P210. Total
numbers of RGLs per DG. p values, WT RGLs at P65 versus P90 = 0.0176; at P90 versus P210 = 0.3655; Ascl1neocKO RGLs at P65 versus P90 = 0.5453; at P90
versus P210 = 0.0525. n = 3 in each condition. Scale bars, 40 mm in (A), (D), (E), (G), and (I) and 10 mm in enlargement of (I). Values represent mean values, and error
bars represent SDs.
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Figure 7. Direct Targets of Ascl1 in Adult Hippocampal Stem Cells
(A–C) Heat map representation of Ascl1-binding signals in adult hippocampus-
derived neural stem cells (AH-NSCs) alongside p300-binding signals in prolif-
eratingNSCsat thesamegenomic locations tomarkenhancers (fromMartynoga
et al. [2013]) (A), and the distribution of Ascl1-binding sites in different classes
of NSC enhancers (from Martynoga et al. [2013]) (B) shows that a large fraction
of Ascl1-binding sites are located in enhancers present in proliferating NSCs,
while reciprocally a large fraction of enhancers present in proliferating NSCs are
bound byAscl1 (C). quies-specific, enhancers specific for quiescentNSCs; pan-
NSC, enhancers present in both quiescent and activated NSCs; active-specific,
enhancers specific for activated NSCs (from Martynoga et al. [2013]).
(D) ChIP-seq signals in AH-NSCs for Ascl1 and the enhancer marks p300 and
H3K27ac (fromMartynoga et al. [2013]) at five genes coding for components of
the cell-cycle machinery. Significant binding peaks are indicated by green
rectangles. Ascl1 binds enhancers in the four genes in AH-NSCs.
(E) Quantitative RT-PCR analysis of fluorescent-activated cell-sorted YFP+
cells from the DG ofWT andAscl1neocKOmice shows that expression of Ascl1
and two Ascl1-bound genes, the cell-cycle genes Ccnd2 and Rrm2, are
strongly reduced in Ascl1neocKO cells, while the expression of Skp2 and Fbl,
two other Ascl1-bound genes, is unchanged. The graph shows expression
levels normalized to Gapdh and Ppia and relative to gene expression in WT.
The remaining Skp2 expression in Ascl1-mutant cells might be due to the
presence of Glast+ parenchymal astrocytes in the sorted population. p values
in WT versus Ascl1neocKO, Ascl1 = 0.0016; Ccnd2 = 0.0016; Rrm2 = 0.0011;
Skp2 = 0.052; Fbl = 0.65. n = 4 in each genotype. Values represent mean
values, and error bars represent SDs.
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Nesorting to purify YFP+ cells from the DG of Ascl1neocKO and WT
mice 4 days after tamoxifen treatment, and we analyzed gene
expression by qRT-PCR. We found that the cyclin Ccnd2 and
the ribonucleotide reductase subunit Rrm2 were significantly
downregulated when Ascl1 was deleted in RGLs, while E2f1
andCdc6 expression were not detectable in either WT or mutant
cells, and expression of Skp2 and non-cell-cycle genes such as
Fbl were not significantly reduced (Figure 7E). Together, these
data demonstrate that Ascl1 controls the proliferation of hippo-
campal RGLs by directly activating the expression of Ccnd2,
Rrm2, and possibly additional cell-cycle genes.
DISCUSSION
Stem cells in adult tissues respond to environmental signals by
adjusting the production of mature cells to the needs of the tis-
sue. Deciphering the pathways that link physiological stimuli to
NSC activity requires characterization of the intrinsic machinery
that controls stem cell activation. We show in this study that
signals regulating hippocampal stem cell activity control the
expression of Ascl1, and that this factor has an essential role in
stem cell activation.
Neurogenic and Antineurogenic Signals Converge on
Ascl1 Expression
Ascl1 expression in the adult brain has often been described as
being restricted to IPCs in the SVZ and DG (Lugert et al., 2012;
Parras et al., 2004). We found, however, that Ascl1 is already ex-
pressed in proliferating RGLs in the hippocampus, in agreement
with earlier studies (Breunig et al., 2007; Kim et al., 2011). Ascl1
expression is then presumably maintained by the IPCs that are
produced when RGLs divide. Most Ascl1+ RGLs are activated,
but only about a third of activated RGLs express Ascl1 detect-
ably, which might be due to an oscillation of Ascl1 expression
in activated RGLs as in embryonic neural progenitor cells (Im-
ayoshi et al., 2013).
The results of our experiments with KA-injected mice suggest
that neurogenic stimuli such as neuronal activity promote stem
cell activation in the hippocampus by inducing Ascl1 expression
in quiescent RGLs. The essential role of Ascl1 in the activation of
adult NSCs suggests that other neurogenic signals controlling
this step, including Wnt signals in the hippocampus (Jang
et al., 2013; Qu et al., 2010, 2013; Seib et al., 2013) and VEGF
in the V-SVZ (Calvo et al., 2011), might also act by inducing
Ascl1 expression. Our results with RBPJk conditional mutant
mice also suggest that antineurogenic stimuli, including the
Notch pathway, suppress stem cell activity by repressing
Ascl1 expression in RGLs. The mechanism by which the
Notch-RBPJk pathway represses Ascl1 expression can be in-
ferred from studies in the embryonic brain and in cancer cells,
which have shown that the Notch-induced Hes factors directly
repress the Ascl1 gene (Kageyama et al., 2005). Moreover, anti-
neurogenic signals may also target Ascl1 protein activity. The
maintenance of hippocampal stem cell quiescence by BMPs
(Mira et al., 2010) may involve an inactivation of Ascl1 protein
by BMP effectors Id proteins, which are known to block Ascl1
activity by preventing its dimerization with E proteins (Nakashima
et al., 2001). FoxO3, which acts downstream of the insulin/IGF-1uron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1093
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cence, shares many targets with Ascl1 and may also function
by antagonizing Ascl1 function (Webb et al., 2013). Inactivation
of Ascl1 protein in RGLs that have begun to transcribe the
Ascl1 gene may be important to slow down the transition to an
active state or to accelerate the return of active RGLs to
quiescence.
Mice carrying the hypomorphic allele Ascl1neoflox express
Ascl1 in the DG at a reduced level and retain only a small fraction
of the proliferating RGLs found in WTmice (Figure 3). The finding
that a change in Ascl1 expression level translates into a change
in the fraction of RGLs that proliferate suggests that extrinsic sig-
nals may fine-tune the rate of hippocampal neurogenesis by
modulating the expression level of Ascl1, as shown for PDK1/
Akt signaling, which regulates Ascl1 protein stability in the em-
bryonic brain (Oishi et al., 2009).
Ascl1 Has a Crucial Role in Hippocampal Stem
Cell Activation
A cell that exits quiescence and transits from the G0 to the early
G1 phase of the cell cycle assembles a prereplication complex
that contains minichromosome maintenance proteins, including
MCM2.MCM2 expression thereforemarks not only cycling cells,
but also activated cells that have exited the quiescent state but
not yet re-entered the cell cycle (Niu et al., 2011; Stoeber
et al., 2001). The glutamate receptor agonist KA induces the
expression of Ascl1 before that of MCM2, indicating that Ascl1
induction is one of the first steps in the pathway through which
neuronal activity promotes the activation of quiescent RGLs.
SinceMCM2 is not expressed in Ascl1-deficient RGLs even after
KA stimulation, Ascl1 is also absolutely required for the quies-
cence exit of hippocampal RGLs.
Because Ascl1-deficient RGLs do not exit the quiescent state,
it is not possible to ascertain whether Ascl1 also regulates the
cell-cycle progression of RGLs. However, Ascl1 promotes the
proliferation of progenitor cells in the embryonic brain (which
do not enter quiescence), and it directly regulates the expression
of cell-cycle regulatory genes in AH-NSCs, including Ccnd2 and
Rrm2, suggesting that it promotes the divisions of hippocampal
RGLs in addition to their activation. Ascl1 has previously been
shown to promote cell proliferation in cancer cells and in the
injured zebrafish retina by regulating Wnt-signaling genes
(Osada et al., 2008; Ramachandran et al., 2011; Rheinbay
et al., 2013). In glioblastoma cancer stem cells (GBM CSCs),
Ascl1 has been shown to bind a site near the Wnt antagonist
gene Dkk1, whose regulation mediates Ascl1 activity in these
cells (Rheinbay et al., 2013). In AH-NSCs, however, Ascl1 does
not bind this site and many other sites bound in GBM CSCs,
and reciprocally, many Ascl1-bound loci were found in AH-
NSCs, and not in GBM CSCs, including sites near the cell-cycle
regulators E2f1,Ccna1,Ccnd2, and Skp2 (data not shown), sug-
gesting that Ascl1 controls the proliferation of hippocampal
RGLs by regulating different genes from those regulated in can-
cer cells and the injured retina.
Transcriptomic and genetic studies suggest that NSCs un-
dergo profound changes in their oxygen and lipid metabolisms
and cell adhesion properties when they exit quiescence (Kno-
bloch et al., 2013; Martynoga et al., 2013; Renault et al., 2009).1094 Neuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc.Further characterization of Ascl1 target genes in RGLs should
elucidate whether Ascl1 directly controls these physiological
changes in addition to promoting cell-cycle re-entry and cell-cy-
cle progression.Ascl1 inactivation also blocks RGL activity in the
V-SVZ. Whether Ascl1 acts through the same downstream
mechanisms in the two adult neurogenic regions remains to be
addressed.
In contrast with the complete lack of RGL activity in the adult
DG in the absence of Ascl1, RGL proliferation was not signifi-
cantly affected by Ascl1 deletion in the early postnatal DG, sup-
porting our earlier finding that Ascl1 is not required for DG
morphogenesis during embryonic development (Galichet et al.,
2008). Interestingly, cell proliferation in the DG becomes also
increasingly dependent on the Ascl1 targetCcnd2 between early
postnatal and adult stages (Ansorg et al., 2012). Therefore, a
switch in the genetic control of DG RGL proliferation occurs dur-
ing the first few weeks of life, with the activation of a mitogenic
pathway involving Ascl1 and Ccnd2.
Ascl1-deficient RGLs remain in Ascl1neocKO mice for at least
5 months without dividing, differentiating, or dying. The perma-
nent cell-cycle arrest can be readily explained by the cell-auton-
omous role of Ascl1 in RGL activation. The lack of astrocyte
differentiation may also be partially explained by the absence
of proliferation, as astrogenesis is normally coupled to RGL divi-
sions (Encinas et al., 2011). However, astrocytes can also be
generated by direct differentiation of RGLs without cell division
(Bonaguidi et al., 2011). In the embryonic brain, activation of
Notch signaling by ligands presented by IPCs and young neu-
rons switches neurogenic progenitors to an astrocytic fate
(Namihira et al., 2009). In the hippocampal SGZ,Ascl1 deficiency
greatly reduces the expression of the Notch effectors Hes1 and
Hes5 (Figure S6D), likely due to the elimination of Notch-ligand-
presenting IPCs and young neurons. The resulting decrease in
Notch activity may thus block the astrocytic differentiation of
Ascl1-deficient RGLs.
Numerous transcription factors have been shown to stimulate
the self-renewal of stem cells in tissues such as the blood and the
skin (Akala and Clarke, 2006; Goldstein and Horsley, 2012).
These factors often act by regulating multiple aspects of the
biology of the stem cells; for example, by suppressing their dif-
ferentiation, senescence, or apoptosis (Lieu and Reddy, 2009;
Souroullas et al., 2009). Only a few factors, such as Gata3 in he-
matopoietic stem cells (Ku et al., 2012) and Runx1 in hair follicle
stem cells (Osorio et al., 2008), have been proposed to primarily
regulate adult stem cell divisions. In the brain, the orphan nuclear
receptor Tlx promotes hippocampal NSC proliferation through
induction of Wnt7a and repression of p21/WAF1 (Niu et al.,
2011; Qu et al., 2010). However, how Tlx is regulated is currently
not known. The function of Ascl1 of controlling adult stem cell ac-
tivity in response to environmental signals is therefore so far
unique in the adult brain. It is akin to that of MyoD in muscle sat-
ellite stem cells, which is expressed shortly after quiescent sat-
ellite cells have been activated, and which in turn induces the
expression of the component of the prereplication complex
Cdc6 (Zhang et al., 2010). Identifying the molecular pathways
that control Ascl1 expression at transcriptional and posttran-
scriptional levels will be important in order to learn how tomanip-
ulate hippocampal neurogenesis for therapeutic purposes.
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Animals
Mice were housed, bred, and treated according to the guidelines approved by
the Home Office under the Animal (Scientific Procedures) Act 1986. All exper-
imental procedures involving mice have been approved by the Animal Welfare
and Ethical Review Panel of the National Institute for Medical Research.
RBPJkloxp/loxp animals were generated as previously described (Han et al.,
2002) and bred to Glast::CreERT2 BAC transgenic mice (Slezak et al., 2007).
Ascl1neoflox/neoflox mice, in which exon 1 of the Ascl1 gene is flanked by loxP
sites (Pacary et al., 2011), were bred with Glast-CreERT2 knockin mice (Mori
et al., 2006) and with Rosa26-floxed stop-YFP reporter mice (Srinivas et al.,
2001) to generate Glast-CreERT2; Ascl1neoflox; R26 YFP mice, which are het-
erozygous for Glast-CreERT2 and homozygous for Ascl1neoflox and R26 YFP.
BothGlast::CreERT2 andGlast-CreERT2 lines target both radial and horizontal
astrocytes in the DG. In order to remove the PGK promoter-neo cassette from
the Ascl1 locus, Ascl1neoflox animals were crossed with actb-Flp mice (The
Jackson Laboratory).
Tamoxifen, BrdU, and KA Administration
For activation of the CreERT2 recombinase, P60 animals were administered
intraperitoneally (i.p.) 4-hydroxytamoxifen (TAM) for 5 consecutive days. For
mosaic experiments, P60 animals received a single TAM injection at the
same concentration. All animals including WT and Ascl1neoflox mice received
TAM injections. To examine proliferating progenitors, mice received a single
i.p. injection of BrdU 2 hr prior to tissue collection. To examine slowly dividing
RGLs, mice received 5 daily BrdU injections followed by 5 consecutive days of
BrdU-containing drinking water. Mice were sacrificed 20 days later. Male mice
received KA as a single i.p. injection and were monitored for 90 min after KA
injection. Animals that did not display rearing and falling were sacrificed 1, 2,
or 4 days later and processed as described below.
Tissue Preparation and Immunofluorescence
Animals were transcardially perfused with saline followed by 4% paraformal-
dehyde (PFA). Brains were postfixedwith 4%PFA for 2 hr at 4C and sectioned
coronally at 40 mmwith a vibratome. The immunofluorescence procedure and
the primary and secondary antibodies are described in Supplemental
Information.
Microscopic Analysis and Quantification
Labeled cells were counted in every ninth 40 mm section through the entire ros-
trocaudal length of the DG (0.82 mm to 4.24 mm from bregma). Counted
cells were divided by the number of z planes counted to obtain the number of
cells per 1 mm, and then multiplied by the total length of the DG. To count
RGLs (GFAP+ radial cells), cells were deemed radial if the cell body clearly asso-
ciated with a DAPI-positive nucleus was located in the SGZ and had a single
radial process extending through at least two-thirds of the granule layer. In all
figures, the cell numbers counted in WT and Ascl1neocKO mice are numbers
of YFP+marker+ double-labeled cells, while the numbers counted inAscl1neoflox
mice are for Ki67+ cells only, since YFP is not expressed in these mice.
Laser-Capture Microdissection, FACS Sorting, RNA Isolation, and
Quantitative Real-Time PCR
Coronal sections 14 mm long were cut from fresh-frozen brains in OCT with a
cryostat and placed on slides. The SGZ of WT, Ascl1neoflox, and Ascl1neocKO
mice was excised by a PLAM laser-capture microdissection system (Zeiss)
and collected in an adhesive cap. RNA from microdissected tissue was ex-
tracted and purified using Arcturus Pico Pure RNA Isolation Kit (Applied Bio-
systems) and reverse transcribed using the High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). Gene expression was detected using
TaqMan Gene Expression Assays (Applied Biosystems). The protocol used
for fluorescent-activated cell sorting is described in Supplemental Information.
Statistical Analyses
Statistical analyses were conducted using a two-sample t test with equal vari-
ance in Prism software. Values represent mean values ± SD.NeNeurosphere Assay
Clonal primary and secondary neurosphere cultures were performed from
dissociated DG dissected from 7- to 8-week-old mice as described (Walker
et al., 2013). The number of neurospheres per well was counted 10 days after
plating.
ChIP-seq Data Generation and Processing
For chromatin immunoprecipitation, adult hippocampus-derived NSCs were
fixed and processed as described (Castro et al., 2011) and immunoprecipi-
tated using a rabbit anti-Ascl1 antibody (Abcam, ab74065, 4.5 mg per ChIP
sample). DNA libraries were prepared and sequences analyzed as described
(Martynoga et al., 2013). A total of 13.5 million nonredundant reads were
used to call peaks, and only peaks with an FDR-corrected q value % 1 3
105 were used for the analysis. p300 and H3K27ac data and active enhancer
definitions in NSCs were from Martynoga et al. [2013]).
ACCESSION NUMBERS
The European Nucleotide Archive accession number for the Ascl1 ChIP-Seq
data reported in this paper is PRJEB5023.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.08.004.
ACKNOWLEDGMENTS
We gratefully acknowledge Lan Chen for helping with AH-NSC cultures, Marie
Caulfield and Rekha Subramaniams for helping manage the mouse colony,
Graham Preece and Wayne Turnbull for helping with flow cytometry, Magda-
lena Go¨tz for providing Glast-CreERT2 mice, Sebastian Jessberger for
providing AH-NSCs, James Brock and HayleyWood for helping with figure de-
signs, Stephen Martin for advice on statistics, Yukiko Gotoh for advice on p57
immunolabeling, and Bertie Go¨ttgens, Alex Gould, Vivian Li, Robin Lovell-
Badge, and the members of the F.G. lab for discussions and comments on
the manuscript. J.A. was supported by a Medical Research Council (MRC)
Studentship and N.U. by an MRC Career Development Fellowship. This
work was supported by a project grant from the Wellcome Trust (082347/Z/
07/Z) and a Grant-in-Aid from the MRC (U117570528) to F.G. and a research
grant from NIH (NIH/NINDS 1R01NS069893) to M.N.
Accepted: August 1, 2014
Published: September 3, 2014
REFERENCES
Ables, J.L., Decarolis, N.A., Johnson, M.A., Rivera, P.D., Gao, Z., Cooper,
D.C., Radtke, F., Hsieh, J., and Eisch, A.J. (2010). Notch1 is required for main-
tenance of the reservoir of adult hippocampal stem cells. J. Neurosci. 30,
10484–10492.
Akala, O.O., and Clarke, M.F. (2006). Hematopoietic stem cell self-renewal.
Curr. Opin. Genet. Dev. 16, 496–501.
Ansorg, A., Witte, O.W., and Urbach, A. (2012). Age-dependent kinetics
of dentate gyrus neurogenesis in the absence of cyclin D2. BMC Neurosci.
13, 46.
Berninger, B., Costa, M.R., Koch, U., Schroeder, T., Sutor, B., Grothe, B., and
Go¨tz, M. (2007). Functional properties of neurons derived from in vitro reprog-
rammed postnatal astroglia. J. Neurosci. 27, 8654–8664.
Bertrand, N., Castro, D.S., and Guillemot, F. (2002). Proneural genes and the
specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530.
Blank, U., Karlsson, G., and Karlsson, S. (2008). Signaling pathways governing
stem-cell fate. Blood 111, 492–503.uron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1095
Neuron
Ascl1 Activates Adult Hippocampal Stem CellsBonaguidi, M.A., Wheeler, M.A., Shapiro, J.S., Stadel, R.P., Sun, G.J., Ming,
G.L., and Song, H. (2011). In vivo clonal analysis reveals self-renewing and
multipotent adult neural stem cell characteristics. Cell 145, 1142–1155.
Bonaguidi, M.A., Song, J., Ming, G.L., and Song, H. (2012). A unifying hypoth-
esis onmammalian neural stem cell properties in the adult hippocampus. Curr.
Opin. Neurobiol. 22, 754–761.
Bracko, O., Singer, T., Aigner, S., Knobloch, M., Winner, B., Ray, J.,
Clemenson, G.D., Jr., Suh, H., Couillard-Despres, S., Aigner, L., et al. (2012).
Gene expression profiling of neural stem cells and their neuronal progeny re-
veals IGF2 as a regulator of adult hippocampal neurogenesis. J. Neurosci.
32, 3376–3387.
Breunig, J.J., Silbereis, J., Vaccarino, F.M., Sestan, N., and Rakic, P. (2007).
Notch regulates cell fate and dendrite morphology of newborn neurons in
the postnatal dentate gyrus. Proc. Natl. Acad. Sci. USA 104, 20558–20563.
Calvo, C.F., Fontaine, R.H., Soueid, J., Tammela, T., Makinen, T., Alfaro-
Cervello, C., Bonnaud, F., Miguez, A., Benhaim, L., Xu, Y., et al. (2011).
Vascular endothelial growth factor receptor 3 directly regulates murine neuro-
genesis. Genes Dev. 25, 831–844.
Castro, D.S., Martynoga, B., Parras, C., Ramesh, V., Pacary, E., Johnston, C.,
Drechsel, D., Lebel-Potter, M., Garcia, L.G., Hunt, C., et al. (2011). A novel
function of the proneural factor Ascl1 in progenitor proliferation identified by
genome-wide characterization of its targets. Genes Dev. 25, 930–945.
Codega, P., Silva-Vargas, V., Paul, A., Maldonado-Soto, A.R., Deleo, A.M.,
Pastrana, E., and Doetsch, F. (2014). Prospective identification and purifica-
tion of quiescent adult neural stem cells from their in vivo niche. Neuron 82,
545–559.
Ehm, O., Go¨ritz, C., Covic, M., Scha¨ffner, I., Schwarz, T.J., Karaca, E.,
Kempkes, B., Kremmer, E., Pfrieger, F.W., Espinosa, L., et al. (2010).
RBPJkappa-dependent signaling is essential for long-term maintenance of
neural stem cells in the adult hippocampus. J. Neurosci. 30, 13794–13807.
Encinas, J.M., Michurina, T.V., Peunova, N., Park, J.H., Tordo, J., Peterson,
D.A., Fishell, G., Koulakov, A., and Enikolopov, G. (2011). Division-coupled as-
trocytic differentiation and age-related depletion of neural stem cells in the
adult hippocampus. Cell Stem Cell 8, 566–579.
Fuchs, E., Tumbar, T., and Guasch, G. (2004). Socializing with the neighbors:
stem cells and their niche. Cell 116, 769–778.
Fuentealba, L.C., Obernier, K., and Alvarez-Buylla, A. (2012). Adult neural stem
cells bridge their niche. Cell Stem Cell 10, 698–708.
Furutachi, S., Matsumoto, A., Nakayama, K.I., and Gotoh, Y. (2013). p57 con-
trols adult neural stem cell quiescence andmodulates the pace of lifelong neu-
rogenesis. EMBO J. 32, 970–981.
Galichet, C., Guillemot, F., and Parras, C.M. (2008). Neurogenin 2 has an
essential role in development of the dentate gyrus. Development 135, 2031–
2041.
Goldstein, J., and Horsley, V. (2012). Home sweet home: skin stem cell niches.
Cell. Mol. Life Sci. 69, 2573–2582.
Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto,M., Nakahata, T.,
Ikuta, K., and Honjo, T. (2002). Inducible gene knockout of transcription factor
recombination signal binding protein-J reveals its essential role in T versus B
lineage decision. Int. Immunol. 14, 637–645.
Imayoshi, I., Isomura, A., Harima, Y., Kawaguchi, K., Kori, H., Miyachi, H.,
Fujiwara, T., Ishidate, F., and Kageyama, R. (2013). Oscillatory control of fac-
tors determining multipotency and fate in mouse neural progenitors. Science
342, 1203–1208.
Jang, M.H., Bonaguidi, M.A., Kitabatake, Y., Sun, J., Song, J., Kang, E., Jun,
H., Zhong, C., Su, Y., Guo, J.U., et al. (2013). Secreted frizzled-related protein
3 regulates activity-dependent adult hippocampal neurogenesis. Cell Stem
Cell 12, 215–223.
Kageyama, R., Ohtsuka, T., Hatakeyama, J., and Ohsawa, R. (2005). Roles of
bHLH genes in neural stem cell differentiation. Exp. Cell Res. 306, 343–348.
Kempermann, G., Jessberger, S., Steiner, B., and Kronenberg, G. (2004).
Milestones of neuronal development in the adult hippocampus. Trends
Neurosci. 27, 447–452.1096 Neuron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc.Kim, E.J., Ables, J.L., Dickel, L.K., Eisch, A.J., and Johnson, J.E. (2011). Ascl1
(Mash1) defines cells with long-term neurogenic potential in subgranular and
subventricular zones in adult mouse brain. PLoS ONE 6, e18472.
Klempin, F., Beis, D., Mosienko, V., Kempermann, G., Bader, M., and Alenina,
N. (2013). Serotonin is required for exercise-induced adult hippocampal neu-
rogenesis. J. Neurosci. 33, 8270–8275.
Knobloch, M., Braun, S.M., Zurkirchen, L., von Schoultz, C., Zamboni, N.,
Arau´zo-Bravo, M.J., Kovacs, W.J., Karalay, O., Suter, U., Machado, R.A.,
et al. (2013). Metabolic control of adult neural stem cell activity by Fasn-depen-
dent lipogenesis. Nature 493, 226–230.
Kronenberg, G., Reuter, K., Steiner, B., Brandt, M.D., Jessberger, S.,
Yamaguchi, M., and Kempermann, G. (2003). Subpopulations of proliferating
cells of the adult hippocampus respond differently to physiologic neurogenic
stimuli. J. Comp. Neurol. 467, 455–463.
Ku, C.J., Hosoya, T., Maillard, I., and Engel, J.D. (2012). GATA-3 regulates
hematopoietic stem cell maintenance and cell-cycle entry. Blood 119, 2242–
2251.
Kuang, S., Gillespie, M.A., and Rudnicki, M.A. (2008). Niche regulation of mus-
cle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22–31.
Lavado, A., Lagutin, O.V., Chow, L.M., Baker, S.J., and Oliver, G. (2010). Prox1
is required for granule cell maturation and intermediate progenitor mainte-
nance during brain neurogenesis. PLoS Biol. 8, e1000460.
Lee, S.W., Clemenson, G.D., and Gage, F.H. (2011). New neurons in an aged
brain. Behav. Brain Res. 227, 497–507.
Lie, D.C., Colamarino, S.A., Song, H.J., De´sire´, L., Mira, H., Consiglio, A., Lein,
E.S., Jessberger, S., Lansford, H., Dearie, A.R., and Gage, F.H. (2005). Wnt
signalling regulates adult hippocampal neurogenesis. Nature 437, 1370–1375.
Lien, W.H., Guo, X., Polak, L., Lawton, L.N., Young, R.A., Zheng, D., and
Fuchs, E. (2011). Genome-wide maps of histone modifications unwind in vivo
chromatin states of the hair follicle lineage. Cell Stem Cell 9, 219–232.
Lieu, Y.K., and Reddy, E.P. (2009). Conditional c-myb knockout in adult
hematopoietic stem cells leads to loss of self-renewal due to impaired prolifer-
ation and accelerated differentiation. Proc. Natl. Acad. Sci. USA 106, 21689–
21694.
Lugert, S., Basak, O., Knuckles, P., Haussler, U., Fabel, K., Go¨tz, M., Haas,
C.A., Kempermann, G., Taylor, V., and Giachino, C. (2010). Quiescent and
active hippocampal neural stem cells with distinct morphologies respond
selectively to physiological and pathological stimuli and aging. Cell Stem
Cell 6, 445–456.
Lugert, S., Vogt, M., Tchorz, J.S., Mu¨ller, M., Giachino, C., and Taylor, V.
(2012). Homeostatic neurogenesis in the adult hippocampus does not involve
amplification of Ascl1(high) intermediate progenitors. Nat. Commun. 3, 670.
Machida, Y.J., Hamlin, J.L., and Dutta, A. (2005). Right place, right time, and
only once: replication initiation in metazoans. Cell 123, 13–24.
Martynoga, B., Mateo, J.L., Zhou, B., Andersen, J., Achimastou, A., Urba´n, N.,
van den Berg, D., Georgopoulou, D., Hadjur, S., Wittbrodt, J., et al. (2013).
Epigenomic enhancer annotation reveals a key role for NFIX in neural stem
cell quiescence. Genes Dev. 27, 1769–1786.
Ming, G.L., and Song, H. (2011). Adult neurogenesis in the mammalian brain:
significant answers and significant questions. Neuron 70, 687–702.
Mira, H., Andreu, Z., Suh, H., Lie, D.C., Jessberger, S., Consiglio, A., San
Emeterio, J., Hortigu¨ela, R., Marque´s-Torrejo´n, M.A., Nakashima, K., et al.
(2010). Signaling through BMPR-IA regulates quiescence and long-term activ-
ity of neural stem cells in the adult hippocampus. Cell Stem Cell 7, 78–89.
Molofsky, A.V., Slutsky, S.G., Joseph, N.M., He, S., Pardal, R., Krishnamurthy,
J., Sharpless, N.E., andMorrison, S.J. (2006). Increasing p16INK4a expression
decreases forebrain progenitors and neurogenesis during ageing. Nature 443,
448–452.
Mori, T., Tanaka, K., Buffo, A., Wurst, W., Ku¨hn, R., and Go¨tz, M. (2006).
Inducible gene deletion in astroglia and radial glia—a valuable tool for func-
tional and lineage analysis. Glia 54, 21–34.
Nagy, A., Moens, C., Ivanyi, E., Pawling, J., Gertsenstein, M., Hadjantonakis,
A.K., Pirity, M., and Rossant, J. (1998). Dissecting the role of N-myc in
Neuron
Ascl1 Activates Adult Hippocampal Stem Cellsdevelopment using a single targeting vector to generate a series of alleles.
Curr. Biol. 8, 661–664.
Nakashima, K., Takizawa, T., Ochiai, W., Yanagisawa, M., Hisatsune, T.,
Nakafuku, M., Miyazono, K., Kishimoto, T., Kageyama, R., and Taga, T.
(2001). BMP2-mediated alteration in the developmental pathway of fetal
mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad.
Sci. USA 98, 5868–5873.
Namihira, M., Kohyama, J., Semi, K., Sanosaka, T., Deneen, B., Taga, T., and
Nakashima, K. (2009). Committed neuronal precursors confer astrocytic po-
tential on residual neural precursor cells. Dev. Cell 16, 245–255.
Niu, W., Zou, Y., Shen, C., and Zhang, C.L. (2011). Activation of postnatal neu-
ral stem cells requires nuclear receptor TLX. J. Neurosci. 31, 13816–13828.
Oishi, K., Watatani, K., Itoh, Y., Okano, H., Guillemot, F., Nakajima, K., and
Gotoh, Y. (2009). Selective induction of neocortical GABAergic neurons by
the PDK1-Akt pathway through activation of Mash1. Proc. Natl. Acad. Sci.
USA 106, 13064–13069.
Orford, K.W., and Scadden, D.T. (2008). Deconstructing stem cell self-
renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9,
115–128.
Osada, H., Tomida, S., Yatabe, Y., Tatematsu, Y., Takeuchi, T., Murakami, H.,
Kondo, Y., Sekido, Y., and Takahashi, T. (2008). Roles of achaete-scute homo-
logue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation
in lung cancer. Cancer Res. 68, 1647–1655.
Osorio, K.M., Lee, S.E., McDermitt, D.J., Waghmare, S.K., Zhang, Y.V., Woo,
H.N., and Tumbar, T. (2008). Runx1 modulates developmental, but not injury-
driven, hair follicle stem cell activation. Development 135, 1059–1068.
Pacary, E., Heng, J., Azzarelli, R., Riou, P., Castro, D., Lebel-Potter, M., Parras,
C., Bell, D.M., Ridley, A.J., Parsons, M., and Guillemot, F. (2011). Proneural
transcription factors regulate different steps of cortical neuron migration
through Rnd-mediated inhibition of RhoA signaling. Neuron 69, 1069–1084.
Parras, C.M., Galli, R., Britz, O., Soares, S., Galichet, C., Battiste, J., Johnson,
J.E., Nakafuku, M., Vescovi, A., and Guillemot, F. (2004). Mash1 specifies neu-
rons and oligodendrocytes in the postnatal brain. EMBO J. 23, 4495–4505.
Pastrana, E., Cheng, L.C., and Doetsch, F. (2009). Simultaneous prospective
purification of adult subventricular zone neural stem cells and their progeny.
Proc. Natl. Acad. Sci. USA 106, 6387–6392.
Ponti, G., Obernier, K., Guinto, C., Jose, L., Bonfanti, L., and Alvarez-Buylla, A.
(2013). Cell cycle and lineage progression of neural progenitors in the ventric-
ular-subventricular zones of adult mice. Proc. Natl. Acad. Sci. USA 110,
E1045–E1054.
Qu, Q., Sun, G., Li, W., Yang, S., Ye, P., Zhao, C., Yu, R.T., Gage, F.H., Evans,
R.M., and Shi, Y. (2010). Orphan nuclear receptor TLX activates Wnt/beta-cat-
enin signalling to stimulate neural stem cell proliferation and self-renewal. Nat.
Cell Biol. 12, 31–40.
Qu, Q., Sun, G.,Murai, K., Ye, P., Li,W., Asuelime, G., Cheung, Y.T., and Shi, Y.
(2013). Wnt7a regulates multiple steps of neurogenesis. Mol. Cell. Biol. 33,
2551–2559.
Ramachandran, R., Zhao, X.F., and Goldman, D. (2011). Ascl1a/Dkk/beta-cat-
enin signaling pathway is necessary and glycogen synthase kinase-3beta inhi-
bition is sufficient for zebrafish retina regeneration. Proc. Natl. Acad. Sci. USA
108, 15858–15863.NeRenault, V.M., Rafalski, V.A., Morgan, A.A., Salih, D.A., Brett, J.O.,Webb, A.E.,
Villeda, S.A., Thekkat, P.U., Guillerey, C., Denko, N.C., et al. (2009). FoxO3 reg-
ulates neural stem cell homeostasis. Cell Stem Cell 5, 527–539.
Rheinbay, E., Suva, M.L., Gillespie, S.M., Wakimoto, H., Patel, A.P., Shahid,
M., Oksuz, O., Rabkin, S.D., Martuza, R.L., Rivera, M.N., et al. (2013). An aber-
rant transcription factor network essential for Wnt signaling and stem cell
maintenance in glioblastoma. Cell Rep. 3, 1567–1579.
Seib, D.R., Corsini, N.S., Ellwanger, K., Plaas, C.,Mateos, A., Pitzer, C., Niehrs,
C., Celikel, T., and Martin-Villalba, A. (2013). Loss of Dickkopf-1 restores neu-
rogenesis in old age and counteracts cognitive decline. Cell Stem Cell 12,
204–214.
Simons, B.D., and Clevers, H. (2011). Strategies for homeostatic stem cell self-
renewal in adult tissues. Cell 145, 851–862.
Slezak, M., Go¨ritz, C., Niemiec, A., Frise´n, J., Chambon, P., Metzger, D., and
Pfrieger, F.W. (2007). Transgenic mice for conditional gene manipulation in as-
troglial cells. Glia 55, 1565–1576.
Souroullas, G.P., Salmon, J.M., Sablitzky, F., Curtis, D.J., and Goodell, M.A.
(2009). Adult hematopoietic stem and progenitor cells require either Lyl1 or
Scl for survival. Cell Stem Cell 4, 180–186.
Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M.,
and Costantini, F. (2001). Cre reporter strains produced by targeted insertion
of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
Stoeber, K., Tlsty, T.D., Happerfield, L., Thomas, G.A., Romanov, S., Bobrow,
L., Williams, E.D., and Williams, G.H. (2001). DNA replication licensing and hu-
man cell proliferation. J. Cell Sci. 114, 2027–2041.
Suh, H., Consiglio, A., Ray, J., Sawai, T., D’Amour, K.A., andGage, F.H. (2007).
In vivo fate analysis reveals the multipotent and self-renewal capacities of
Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell 1, 515–528.
Venezia, T.A., Merchant, A.A., Ramos, C.A., Whitehouse, N.L., Young, A.S.,
Shaw, C.A., and Goodell, M.A. (2004). Molecular signatures of proliferation
and quiescence in hematopoietic stem cells. PLoS Biol. 2, e301.
Vooijs, M., Jonkers, J., and Berns, A. (2001). A highly efficient ligand-regulated
Cre recombinase mouse line shows that LoxP recombination is position
dependent. EMBO Rep. 2, 292–297.
Walker, T.L., Wierick, A., Sykes, A.M., Waldau, B., Corbeil, D., Carmeliet, P.,
and Kempermann, G. (2013). Prominin-1 allows prospective isolation of neural
stem cells from the adult murine hippocampus. J. Neurosci. 33, 3010–3024.
Webb, A.E., Pollina, E.A., Vierbuchen, T., Urba´n, N., Ucar, D., Leeman, D.S.,
Martynoga, B., Sewak, M., Rando, T.A., Guillemot, F., et al. (2013). FOXO3
shares common targets with ASCL1 genome-wide and inhibits ASCL1-depen-
dent neurogenesis. Cell Rep. 4, 477–491.
Yang, N., Ng, Y.H., Pang, Z.P., Su¨dhof, T.C., and Wernig, M. (2011). Induced
neuronal cells: how to make and define a neuron. Cell Stem Cell 9, 517–525.
Zhang, C.L., Zou, Y., He, W., Gage, F.H., and Evans, R.M. (2008). A role for
adult TLX-positive neural stem cells in learning and behaviour. Nature 451,
1004–1007.
Zhang, K., Sha, J., and Harter, M.L. (2010). Activation of Cdc6 by MyoD is
associated with the expansion of quiescent myogenic satellite cells. J. Cell
Biol. 188, 39–48.uron 83, 1085–1097, September 3, 2014 ª2014 Elsevier Inc. 1097
